
Opinion|Videos|July 10, 2024
Key Financial Factors Associated With Typical PNH Treatment Journey
Dr Haumschild and a panel of medical experts underscore financial considerations in PNH treatment.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Please walk us through the typical patient journey for individuals with PNH, highlighting the key touchpoints, challenges, and unmet needs encountered along the way.
- What challenges, beyond coverage approval, have you faced in ensuring seamless access to PNH medications for patients, and how do financial factors impact your treatment decisions?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
3
Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD
4
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
5





